CSI Market
Sign In | Register

Day One Biopharmaceuticals Inc (DAWN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DAWN Annual Balance Sheets →
The data below summarizes Day One Biopharmaceuticals Inc's balance sheet position from Dec 31 2024 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Assets
Cash & cash equivalent197.08
Short-term Investments, Total244.04
Cash & Short-term Investments441.00
Accounts receivable26.74
Inventories6.33
Other Current Assets0.00
Prepaid Expense And Other Assets Current10.93
Total Current Assets485.10
Equipment/Property/Plant Net2.14
Intangible Assets18.02
Operating Lease Right Of Use Asset2.34
Deposits And Other Longterm Assets Non Current0.23
Total Assets507.83
Liabilities
Accounts Payable, Current AC3.73
Accrued Liabilities And Other Liabilities54.62
Other Liabilities, Current0.17
Deferred Revenue, Current DE2.00
Total Current Liabilities60.52
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE3.04
Other liabilities, Noncurrent3.10
OperatingLeaseLiabilityNoncurrent2.62
Operating Lease Liability Current0.17
Total Liabilities66.67
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,102.49
Retained Earnings / Accumulated Deficit-661.40
Other Equity0.07
Common Stockholder's Equity441.16
Total Stockholder's Equity441.16
Liabilities & Stockholder's Equity507.83
4 historic quarters locked

Sign in to unlock the full Day One Biopharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Day One Biopharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-25-264649

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.